C
CG Oncology Inc
NASDAQ:CGON
CG Oncology Inc
NASDAQ:CGON
Price:
50.85
USD
-2.17%
Market Closed
Market Cap:
$4.1B
Cash Flow Statement
Cash Flow Statement
CG Oncology Inc
CG Oncology Inc
Currency: USD
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(49)
|
(66)
|
(84)
|
(72)
|
(88)
|
(106)
|
(128)
|
(151)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Stock-Based Compensation |
2
|
3
|
5
|
7
|
11
|
15
|
20
|
24
|
|
| Other Non-Cash Items |
(1)
|
(1)
|
(1)
|
(2)
|
6
|
12
|
17
|
23
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
3
|
(5)
|
(2)
|
0
|
3
|
12
|
17
|
11
|
|
| Cash from Operating Activities |
(46)
N/A
|
(72)
-57%
|
(88)
-22%
|
(74)
+16%
|
(79)
-6%
|
(82)
-4%
|
(94)
-14%
|
(117)
-24%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(121)
|
(429)
|
(465)
|
(295)
|
(301)
|
(180)
|
(142)
|
(159)
|
|
| Cash from Investing Activities |
(121)
N/A
|
(429)
-254%
|
(465)
-8%
|
(295)
+37%
|
(301)
-2%
|
(180)
+40%
|
(142)
+21%
|
(159)
-12%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
107
|
513
|
513
|
409
|
632
|
226
|
226
|
278
|
|
| Net Issuance of Debt |
(16)
|
(17)
|
(17)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Other |
(3)
|
(7)
|
(7)
|
(7)
|
(3)
|
(0)
|
(1)
|
(0)
|
|
| Cash from Financing Activities |
87
N/A
|
490
+463%
|
490
+0%
|
402
-18%
|
628
+56%
|
226
-64%
|
226
0%
|
278
+23%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
(80)
N/A
|
(11)
+87%
|
(63)
-490%
|
33
N/A
|
249
+651%
|
(36)
N/A
|
(11)
+71%
|
2
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(46)
N/A
|
(72)
-57%
|
(88)
-23%
|
(74)
+16%
|
(79)
-6%
|
(82)
-4%
|
(94)
-14%
|
(117)
-25%
|
|
Switch to:
Switch to:
See Also
Discover More
